Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48,507,463
-
Total 13F shares
-
19,758,281
-
Share change
-
+19,169,179
-
Total reported value
-
$344,315,360
-
Price per share
-
$17.44
-
Number of holders
-
45
-
Value change
-
+$334,041,398
-
Number of buys
-
44
Institutional Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q2 2021
As of 30 Jun 2021 Werewolf Therapeutics, Inc. - Common Stock (HOWL) had 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,758,281 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MPM Oncology Impact Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., SPHERA FUNDS MANAGEMENT LTD., Avidity Partners Management LP, DC Funds, LP, Soleus Capital Management, L.P., and PFM Health Sciences, LP.
This table shows 45 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.